[go: up one dir, main page]

FI20011403L - Menetelmä ja koostumukset vatsan sairauksien hoitoon - Google Patents

Menetelmä ja koostumukset vatsan sairauksien hoitoon Download PDF

Info

Publication number
FI20011403L
FI20011403L FI20011403A FI20011403A FI20011403L FI 20011403 L FI20011403 L FI 20011403L FI 20011403 A FI20011403 A FI 20011403A FI 20011403 A FI20011403 A FI 20011403A FI 20011403 L FI20011403 L FI 20011403L
Authority
FI
Finland
Prior art keywords
compositions
treating stomach
stomach diseases
diseases
treating
Prior art date
Application number
FI20011403A
Other languages
English (en)
Swedish (sv)
Other versions
FI20011403A7 (fi
Inventor
Jari Natunen
Halina Miller-Podraza
Susann Teneberg
Jonas Aangstroem
Karl-Anders Karlsson
Original Assignee
Carbion Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carbion Oy filed Critical Carbion Oy
Priority to FI20011403A priority Critical patent/FI20011403A7/fi
Priority to EP02751213A priority patent/EP1411953A1/en
Priority to JP2003508367A priority patent/JP2004537538A/ja
Priority to PCT/FI2002/000575 priority patent/WO2003002128A1/en
Priority to JP2003508366A priority patent/JP2005504017A/ja
Priority to AU2002352533A priority patent/AU2002352533A1/en
Priority to EP02751212A priority patent/EP1411952B1/en
Priority to DE60232077T priority patent/DE60232077D1/de
Priority to PCT/FI2002/000574 priority patent/WO2003002127A1/en
Priority to AT02751212T priority patent/ATE429233T1/de
Priority to AU2002352531A priority patent/AU2002352531A1/en
Priority to US10/482,045 priority patent/US20040176320A1/en
Priority to US10/482,046 priority patent/US20040180850A1/en
Publication of FI20011403L publication Critical patent/FI20011403L/fi
Publication of FI20011403A7 publication Critical patent/FI20011403A7/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI20011403A 2001-06-29 2001-06-29 Menetelmä ja koostumukset vatsan sairauksien hoitoon FI20011403A7 (fi)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FI20011403A FI20011403A7 (fi) 2001-06-29 2001-06-29 Menetelmä ja koostumukset vatsan sairauksien hoitoon
EP02751213A EP1411953A1 (en) 2001-06-29 2002-06-28 Methods and compositions for treatment of gastric diseases
JP2003508367A JP2004537538A (ja) 2001-06-29 2002-06-28 胃疾患を治療するための方法および組成物
PCT/FI2002/000575 WO2003002128A1 (en) 2001-06-29 2002-06-28 Methods and compositions for treatment of gastric diseases
JP2003508366A JP2005504017A (ja) 2001-06-29 2002-06-28 少なくとも１種の糖含有阻害性物質の用途
AU2002352533A AU2002352533A1 (en) 2001-06-29 2002-06-28 Methods and compositions for treatment of gastric diseases
EP02751212A EP1411952B1 (en) 2001-06-29 2002-06-28 Use of at least one glycoinhibitor substance against infectious diseases
DE60232077T DE60232077D1 (de) 2001-06-29 2002-06-28 Verwendung mindestens einer glycoinhibitor-substanz gegen infektionskrankheiten
PCT/FI2002/000574 WO2003002127A1 (en) 2001-06-29 2002-06-28 Use of at least one glycoinhibitor substance
AT02751212T ATE429233T1 (de) 2001-06-29 2002-06-28 Verwendung mindestens einer glycoinhibitor- substanz gegen infektionskrankheiten
AU2002352531A AU2002352531A1 (en) 2001-06-29 2002-06-28 Use of at least one glycoinhibitor substance
US10/482,045 US20040176320A1 (en) 2001-06-29 2002-06-28 Use of at least one glycoinhibitor substance
US10/482,046 US20040180850A1 (en) 2001-06-29 2002-06-28 Methods and compositions for treatment of gastric diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20011403A FI20011403A7 (fi) 2001-06-29 2001-06-29 Menetelmä ja koostumukset vatsan sairauksien hoitoon

Publications (2)

Publication Number Publication Date
FI20011403L true FI20011403L (fi) 2002-12-30
FI20011403A7 FI20011403A7 (fi) 2002-12-30

Family

ID=8561536

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20011403A FI20011403A7 (fi) 2001-06-29 2001-06-29 Menetelmä ja koostumukset vatsan sairauksien hoitoon

Country Status (6)

Country Link
US (1) US20040180850A1 (fi)
EP (1) EP1411953A1 (fi)
JP (1) JP2004537538A (fi)
AU (1) AU2002352533A1 (fi)
FI (1) FI20011403A7 (fi)
WO (1) WO2003002128A1 (fi)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003059924A1 (en) * 2002-01-18 2003-07-24 Biotie Therapies Corporation Novel binding epitopes for helicobacter pylori and use thereof
FI20021989A0 (fi) * 2002-11-06 2002-11-06 Halina Miller-Podraza Korkean affiniteetin Helicobacter pylori-reseptorit ja niiden käyttö
WO2004065400A1 (en) * 2003-01-20 2004-08-05 Glykos Finland Oy Novel binding epitopes for helicobacter pylori and use thereof
US20070020358A1 (en) * 2005-03-18 2007-01-25 Mower Thomas E Sports drink concentrate
US7776365B2 (en) * 2005-03-18 2010-08-17 Sakura Properties, Llc Article with skin protecting and moisturizing compound
US20060210688A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Dehydrated sports drink powder
US20060210692A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Baby food composition
US7666448B2 (en) 2005-03-18 2010-02-23 Sakura Properties, Llc Skin cleansing article
US20060210697A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Infant formula composition
US7749545B2 (en) * 2005-03-18 2010-07-06 Sakura Properties, Llc Fucoidan compositions and methods for dietary and nutritional supplements
US20060210496A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Compositions for skin protection from ultraviolet damage
JP5035787B2 (ja) * 2005-10-04 2012-09-26 焼津水産化学工業株式会社 α−１、４結合型Ｎ−アセチルグルコサミン含有Ｏ−グリカン型糖鎖の分泌促進剤並びにこれを含有するヘリコバクターピロリ菌を原因とする病態の治療予防剤
US11510894B2 (en) * 2006-01-27 2022-11-29 John P. Geibel Fast acting inhibitor of gastric acid secretion
US8512761B2 (en) * 2006-01-27 2013-08-20 Yale University Fast acting inhibitor of gastric acid secretion
JP5140246B2 (ja) * 2006-03-15 2013-02-06 公益財団法人野口研究所 Ｎ−アセチルグルコサミンの誘導体を含有するピロリ菌増殖抑制剤
JPWO2008032817A1 (ja) * 2006-09-14 2010-01-28 独立行政法人理化学研究所 抗ピロリ菌活性を有する糖鎖
JP5014018B2 (ja) * 2006-10-18 2012-08-29 旭化成ケミカルズ株式会社 ピロリ菌の抑制剤または静菌剤
JP5501969B2 (ja) * 2007-09-11 2014-05-28 ユニバーシティ オブ グェルフ クロストリジウム・ディフィシル由来の多糖免疫原
WO2009104649A1 (ja) * 2008-02-22 2009-08-27 片山化学工業株式会社 合成糖脂質含有リポソーム
RU2410100C2 (ru) * 2009-03-30 2011-01-27 Александр Владимирович Диковский Фармацевтическая композиция ингибитора протонной помпы и пребиотика для лечения язвенных поражений желудка и 12-перстной кишки
US9511080B2 (en) 2009-12-31 2016-12-06 Okada Medical Services Pty Ltd Okadaella gastrococcus and cancer
RU2665948C1 (ru) * 2017-08-22 2018-09-05 Анастасия Владимировна Серебрянская Лекарственный препарат для наружного применения
CN113274404A (zh) * 2020-06-28 2021-08-20 天翊生物医药科技(天津)有限公司 医用吸附树脂的新用途及幽门螺杆菌消除药物
CN112842997B (zh) * 2021-04-08 2022-08-12 青岛海洋生物医药研究院股份有限公司 一种同时抑制幽门螺旋杆菌和具核梭杆菌的口服海洋多糖纳米胶束及其制备方法和应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
JPH0220292A (ja) * 1988-07-06 1990-01-23 Agency Of Ind Science & Technol 低分子化キトサンの製造方法
US5217715A (en) * 1988-08-01 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Carbohydrate receptor for bacteria and method for use thereof
US5204118A (en) * 1989-11-02 1993-04-20 Mcneil-Ppc, Inc. Pharmaceutical compositions and methods for treating the symptoms of overindulgence
US5651968A (en) * 1991-08-23 1997-07-29 Alberta Research Council Methods and compositions for attenuating antibody-mediated xenograft rejection in human recipients
MX9304638A (es) * 1992-07-31 1994-05-31 Neose Pharm Inc Composicion para tratar e inhibir las ulceras gastricas y duodenales.
ES2119818T3 (es) * 1992-08-13 1998-10-16 Teikoku Seiyaku Kk Preparacion oral para liberacion en el tracto digestivo inferior.
US5679375A (en) * 1995-06-07 1997-10-21 C.V. Therapeuctics Method of treating ulcers with sulfated polysaccharides
WO1997041875A1 (en) * 1996-05-03 1997-11-13 Neose Technologies, Inc. Bismuth salt of sialyloligosaccharide and a method for treating and inhibiting gastric and duodenal ulcers with same
HU225329B1 (en) 1996-09-12 2006-09-28 Richter Gedeon Vegyeszet Use of zinc or cobalt hyaluronate associate for the manufacture of pharmaceutical compositions of antimicrobial activity
CA2300082A1 (en) * 1998-06-09 1999-12-16 Ghen Corporation Fixation inhibitors for helicobacter pylori
AU5062099A (en) * 1998-07-21 2000-02-14 Alpenstock Holdings Limited An antilipemic formulation
EP1120100B1 (en) 1998-10-05 2005-08-17 Kabushiki Kaisha Yakult Honsha Antibacterial agents and process for producing the same
KR100324441B1 (ko) * 1999-02-08 2002-02-27 이은선 위염, 위궤양, 십이지장궤양 예방을 위한 식품
SE9901007D0 (sv) * 1999-03-19 1999-03-19 Thomas Boren Use of fucosylated sialylated N-acetyl lactosamin carbohydrate structures for inhibition of bacterial adherence
SE9904581D0 (sv) * 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof
US6492350B2 (en) * 2000-01-27 2002-12-10 Jdc (Hawaii) Inc. Chitin oligosaccharides and/or chitosan oligosaccharides for preventing or treating common cold or treating pain
US20020119928A1 (en) * 2000-10-27 2002-08-29 Mcanalley Bill H. Dietary supplement compositions

Also Published As

Publication number Publication date
AU2002352533A1 (en) 2003-03-03
JP2004537538A (ja) 2004-12-16
EP1411953A1 (en) 2004-04-28
FI20011403A7 (fi) 2002-12-30
WO2003002128A1 (en) 2003-01-09
US20040180850A1 (en) 2004-09-16

Similar Documents

Publication Publication Date Title
FI20011403L (fi) Menetelmä ja koostumukset vatsan sairauksien hoitoon
NO20040873L (no) Fremgangsmate og anordning for sammensetting av gjenfestbare absorberende klesplagg
AUPR638101A0 (en) Composition and method for treatment of disease
NO20024610L (no) Synergistiske metoder og blandinger for behandling av kreft
ATE430555T1 (de) Pharmazeutische zusammensetzungen zur behandlung von asthma
NO20035156D0 (no) Fremgangsmåter for brönnbehandling
NO20035609L (no) Fremgangsmate for kontinuerlig naftabehandling
FI20010367A7 (fi) Menetelmä ja järjestely häiriön vaimentamiseksi
AU2002243023A1 (en) Compositions for preventing and/or treating oral diseases
GB0110288D0 (en) Composition and treatment method
ATE326842T1 (de) Zusammensetzung zur saatgutbehandlung
NO20041004L (no) Fremgangsmate og anordning for sammensetting av gjenfestbare absorberende klesplagg
FIU20060389U0 (fi) Luusairauksien hoito
EP1395215A4 (en) QUINOLONE CARBOXYLIC ACID COMPOSITIONS AND METHODS OF TREATMENT THEREOF
DE60223576D1 (de) Hautbehandlungszusammensetzung
EP1461047A4 (en) COMPOSITIONS AND METHODS FOR TREATING ANIMALS
DE60236743D1 (de) Zur behandlung androgenabhängiger krankheiten
NO20042012L (no) Sammensetning og fremgangsmate for behandling av diabetes
FI20010075L (fi) Terveysvaikutteinen tuote ja menetelmä
EP1385947A4 (en) COMPOSITIONS AND METHODS FOR REGULATING BLEEDING
EP1450820A4 (en) METHOD OF TREATING AND PREVENTING INFLAMMATORY DISEASES
ATE297914T1 (de) Hydroxyphenyl-piperazinyl-methyl-benzamid- derivate zur schmerzbehandlung
GB0112216D0 (en) Method of treatment
EE200300057A (et) Koostis vähi profülaktikaks ja raviks
ATE418339T1 (de) Zusammensetzung und verfahren